AI-based methods for modelling whole-slide imaging data in cancer diagnosis and transcriptome profile prediction

Whole Slide Imaging (WSI) has transformed digital pathology by enabling digitization of histological slides at gigapixel resolution. Artificial intelligence (AI), particularly deep learning (DL), models have leveraged WSIs to improve cancer diagnostics and, more recently, to infer transcriptomic profiles directly from tissue morphology. Although image analysis methods have made rapid progress and been widely reviewed before, specific challenges arise in dealing with domain-specific issues in WSI data. This review systematically surveys recent progress in AI-based analysis, focusing on two key predictive tasks namely, (i) cancer diagnosis and characterization and (ii) transcriptome or gene expression profile prediction from WSI samples. Giving a brief overview of WSI data collection and analysis in historical perspective, we review the techniques developed for diagnostic tasks, in the areas of model architectures such as Convolutional Neural Networks (CNNs), Vision Transformers, and Multiple Instance Learning (MIL). For the less studied but emerging problem of transcriptomic prediction, we discuss leading models such as HE2RNA, SEQUOIA, and tRNAsformer, their generalizability, and evaluation metrics (e.g. AUC, C-index, Pearson correlation). We highlight how AI models have achieved high diagnostic accuracy through specific, pan-cancer and multimodal foundation models and how the field is likely to evolve. AI-enabled WSI analysis shows substantial promise for both diagnostic and molecular inference tasks in oncology. However, key limitations such as spatial resolution constraints, lack of external validation, biological interpretability and clinical integration barriers need further development of methodologies in both directions. Specifically, future efforts need to address multimodal data integration, improved interpretability, and rigorous validation in diverse cohorts to realise the full potential of their clinical translation.

Authors

Institutions

Publication Details

Journal
BMC Artificial Intelligence
Published
2025-12-30
DOI
https://doi.org/10.1186/s44398-025-00018-1
Citations
1
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
2.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI-based methods for modelling whole-slide imaging data in cancer diagnosis and transcriptome profile prediction

Jyoti Singh Kirar, Arfa Jabin, Shandar Ahmad
1 citations
BMC Artificial Intelligence
AI in cancer detection
2.48
article

AI-based methods for modelling whole-slide imaging data in cancer diagnosis and transcriptome profile prediction

Jyoti Singh Kirar, Arfa Jabin, Shandar Ahmad
article en
1 citations

Abstract

Whole Slide Imaging (WSI) has transformed digital pathology by enabling digitization of histological slides at gigapixel resolution. Artificial intelligence (AI), particularly deep learning (DL), models have leveraged WSIs to improve cancer diagnostics and, more recently, to infer transcriptomic profiles directly from tissue morphology. Although image analysis methods have made rapid progress and been widely reviewed before, specific challenges arise in dealing with domain-specific issues in WSI data. This review systematically surveys recent progress in AI-based analysis, focusing on two key predictive tasks namely, (i) cancer diagnosis and characterization and (ii) transcriptome or gene expression profile prediction from WSI samples. Giving a brief overview of WSI data collection and analysis in historical perspective, we review the techniques developed for diagnostic tasks, in the areas of model architectures such as Convolutional Neural Networks (CNNs), Vision Transformers, and Multiple Instance Learning (MIL). For the less studied but emerging problem of transcriptomic prediction, we discuss leading models such as HE2RNA, SEQUOIA, and tRNAsformer, their generalizability, and evaluation metrics (e.g. AUC, C-index, Pearson correlation). We highlight how AI models have achieved high diagnostic accuracy through specific, pan-cancer and multimodal foundation models and how the field is likely to evolve. AI-enabled WSI analysis shows substantial promise for both diagnostic and molecular inference tasks in oncology. However, key limitations such as spatial resolution constraints, lack of external validation, biological interpretability and clinical integration barriers need further development of methodologies in both directions. Specifically, future efforts need to address multimodal data integration, improved interpretability, and rigorous validation in diverse cohorts to realise the full potential of their clinical translation.

BMC Artificial IntelligenceVol. 1(1)
Jawaharlal Nehru University (IN)
Openalex Percentile: Top 6%
AI in cancer detection
2.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

AI-based methods for modelling whole-slide imaging data in cancer diagnosis and transcriptome profile prediction — Jyoti Singh Kirar, Arfa Jabin, et al. · BMC Artificial Intelligence (2025) | TGRS Research Map | TGRS